二甲双胍硫化氢盐的合成、结构鉴定和稳定性研究

doi:10.6023/cjoc201811031

有机化学 ›› 2019, Vol. 39 ›› Issue (5): 1503-1508.DOI: 10.6023/cjoc201811031 上一篇下一篇

研究简报

二甲双胍硫化氢盐的合成、结构鉴定和稳定性研究

胡曰富^a, 崔桂玲^a, 黄文才^b, 杨黎^c, 齐庆蓉^a

a 四川大学华西药学院靶向药物与释药系统教育部重点实验室四川省植物来源药物工程实验室四川省药物精密工业技术研究中心成都 610041;
b 四川大学化学工程学院成都 610065;
c 四川大学华西医院肿瘤中心成都 610041

收稿日期:2018-11-26 修回日期:2018-12-26 发布日期:2019-01-10
通讯作者: 杨黎, 齐庆蓉 E-mail:yangli@scu.edu.cn;qiqingrong@scu.edu.cn
基金资助:
石药集团心脑血管药物创新综合平台建设基金（No.2013ZX09402103-1）资助项目.

Synthesis, Structural Characterization and Stability Evaluation of Metformin Hydrosulfide

Hu Yuefu^a, Cui Guiling^a, Huang Wencai^b, Yang Li^c, Qi Qingrong^a

a Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center of Drug Precision Industrial Technology for Small Molecule Drugs, West China School of Pharmacy, Sichuan University, Chengdu 610041;
b School of Chemical Engineering, Sichuan University, Chengdu 610065;
c Cancer Center, West China Hospital, Sichuan University, Chengdu 610041

Received:2018-11-26 Revised:2018-12-26 Published:2019-01-10
Contact: 10.6023/cjoc201811031 E-mail:yangli@scu.edu.cn;qiqingrong@scu.edu.cn
Supported by:
Project supported by the Construction of a Comprehensive Platform for the Innovation of Cardio-cerebrovascular Drugs in Shijiazhuang Pharmaceutical Group Company Limited (No. 2013ZX09402103-1).

文章分享

1. 二甲双胍硫化氢盐的合成、结构鉴定和稳定性研究.PDF(914KB)

摘要/Abstract

随着硫化氢作为人体内重要内源性气体信号分子研究的不断深入，有机小分子硫化氢供体的研究也取得了较大的进展，但目前尚无一种硫化氢供体药物上市.二甲双胍是临床上治疗糖尿病的一线药物，近年来被报道还具有减肥、抗癌、抗衰老等多种生理活性.鉴于硫化氢和二甲双胍在重大疾病治疗中的良好前景，设计了一种全新的硫化氢供体二甲双胍硫化氢盐，前人对该类有机碱硫化氢盐的系统研究几乎为空白，更无将其作为硫化氢供体的报道.首先将二甲双胍盐酸盐处理得到二甲双胍游离碱，再与硫化氢反应形成二甲双胍硫化氢盐.通过氢谱、碳谱、元素分析及X单晶衍射对其进行了结构确证.采用碘量法、醋酸铅法和荧光亚甲蓝法测定了二甲双胍硫化氢盐中硫化氢的含量，均大于96.00%；采用高效液相色谱（HPLC）测定了二甲双胍硫化氢盐中二甲双胍的含量大于98.50%，且二甲双胍硫化氢盐的溶液及固体均相对稳定.上述研究结果表明，二甲双胍硫化氢盐有望作为一种新结构类型的硫化氢供体进行深入的研究和开发.

关键词: 二甲双胍硫化氢盐, 硫化氢供体, 硫化氢治疗

Hydrogen sulfide (H₂S), the third gas signal molecule in mammals is studied more and more deeply, and great progress has been made on organic small molecule hydrogen sulfide donors. However, no hydrogen sulfide donor has been marketed as a drug yet. Metformin is a first-line drug for the treatment of diabetes. And some other biological activities such as anti-obesity, anticancer, and anti-aging have been disclosed in recent years. H₂S donor has also shown promising prospect in antitumor, cardiovascular protection, anti-inflammation, ion channel regulation and anti-oxidation activities. In view of the potential of hydrogen sulfide and metformin for treatment of diseases, a novel hydrogen sulfide donor, metformin hydrosulfide, was thus designed. Till now, there is no report of this type of hydrogen sulfide donor. In our work, metformin hydrochloride was first basified to obtain metformin, followed by reaction with hydrogen sulfide to afford metformin hydrosulfide. The structure was fully characterized by ¹H NMR, ¹³C NMR, elemental analysis and X-ray crystal. The content of hydrogen sulfide was determined by iodometry method, lead acetate test and methylene blue spectrophotometric method to be more than 96.00%. The metformin level was determined by high-pressure liquid chromatography (HPLC) to be more than 98.50%. The stability of metformin hydrosulfide was evaluated by iodometry method in solution and solid, respectively. The results indicate that metformin hydrosulfide is a promising new type of hydrogen sulfide donor which deserves further research and development.

Key words: metformin hydrosulfide, hydrogen sulfide donor, hydrogen sulfide-based therapeutics

引用此文

胡曰富, 崔桂玲, 黄文才, 杨黎, 齐庆蓉. 二甲双胍硫化氢盐的合成、结构鉴定和稳定性研究[J]. 有机化学, 2019, 39(5): 1503-1508.

Hu Yuefu, Cui Guiling, Huang Wencai, Yang Li, Qi Qingrong. Synthesis, Structural Characterization and Stability Evaluation of Metformin Hydrosulfide[J]. Chin. J. Org. Chem., 2019, 39(5): 1503-1508.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] (a) Zheng, Y.; Yu, B.; De La Cruz, L. K.; Roy Choudhury, M.; Anifowose, A.; Wang, B. H. Med. Res. Rev. 2018, 38, 57.
(b) Guo, W.; Cheng, Z. Y.; Zhu, Y. Z. Acta Pharmacol. Sin. 2013, 34, 1284.
(c) Wallace, J. L.; Wang, R. Nat. Rev. Drug Discovery 2015, 14, 329.
(d) Zhou, C.; Qiu, B.; Zeng, Y.; Chen, J. P.; Yu, T. J.; Li, Y. Chin. J. Org. Chem. 2017, 37, 92(in Chinese). (周婵, 邱波, 曾毅, 陈金平, 于天君, 李嫕, 有机化学, 2017, 37, 92.)
[2] (a) Hellmich, M. R.; Szabo, C. In Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide, Vol. 230, Eds.:Moore, P. K.; Whiteman, M., Springer, Switzerland, 2015, p. 233.
(b) Zhao, Y.; Kang, J. M.; Park, C. M.; Bagdon, P. E.; Peng, B.; Xian, M. Org. Lett. 2014, 16, 4536.
(c) Gao, M.; Yu, F. B.; Chen, L. X. Prog. Chem. 2014, 6, 1065(in Chinese). (高敏, 于发标, 陈令新, 化学进展, 2014, 6, 1065.)
[3] (a) Sparatore, A.; Santus, G.; Giustarini, D.; Rossi, R.; Del Soldato, P. Expert Rev. Clin. Pharmacol. 2011, 4, 109.
(b) Zhang, X. Z.; Bian, J. S. ACS Chem Neurosci. 2014, 5, 876.
(c) Zhao, Y.; Yang, C. T.; Organ, C.; Li, Z.; Bhushan, S. S.; Otsuka, H.; Pacheco, A.; Kang, J. M.; Aguilar, H. C.; Lefer, D. J.; Xian, M. J. Med. Chem. 2015, 58, 7501.
(d) Kang, J. M.; Li, Z.; Organ, C. L.; Park, C. M.; Yang, C. T.; Pacheco, A.; Wang, D. F.; Lefer, D. J.; Xian, M. J. Am. Chem. Soc. 2016, 138, 6336.
(e) He, P.; Tang, L. J.; Zhong, K. L.; Hou, S. H.; Yan, X. M. Chin. J. Org. Chem. 2017, 37, 423(in Chinese). (何平, 汤立军, 钟克利, 侯淑华, 燕小梅, 有机化学, 2017, 37, 423.)
[4] (a) Benavides, G. A.; Squadrito, G. L.; Mills, R. W.; Patel, H. D.; Isbell, T. S.; Patel, R. P.; DarleyUsmar, V. M.; Doeller, J. E.; Kraus, D. W. Proc. Natl. Acad. Sci. 2007, 104, 17977.
(b) Liang, D.; Wu, H.; Wong, M. W.; Huang, D. Org. Lett. 2015, 17, 4196.
[5] (a) Zhao, Y.; Biggs, T. D.; Xian, M. Chem. Commun. (Camb.) 2014, 50, 11788.
(b) Martelli, A.; Testai, L.; Citi, V.; Marino, A.; Pugliesi, I.; Barresi, E.; Nesi, G.; Rapposelli, S.; Taliani, S.; Da Settimo, F.; Breschi, M. C.; Calderone, V. ACS Med. Chem. Lett. 2013, 4, 904.
[6] (a) Martelli, A.; Testai, L.; Citi, V.; Marino, A.; Bellagambi, F. G.; Ghimenti, S.; Breschi, M. C.; Calderone, V. Vasc. Pharmacol. 2014, 60, 32.
(b) Citi, V.; Martelli, A.; Testai, L.; Marino, A.; Breschi, M. C.; Calderone, V. Planta Med. 2014, 80, 610.
[7] Zhao, Y.; Wang, H.; Xian, M. J. Am. Chem. Soc. 2011, 133, 15.
[8] Ozturk, T.; Ertas, E.; Mert, O. Chem. Rev. 2007, 107, 5210.
[9] (a) Qandil, A. M. Int. J. Mol. Sci. 2012, 13, 17244.
(b) Li, L.; Rossoni, G.; Sparatore, A.; Lee, L. C.; Del Soldato, P.; Moore, P. K. Free Radicals Biol. Med. 2007, 42, 706.
[10] (a) Wallace, J. L.; Caliendo, G.; Santagada, V.; Cirino, G.; Fiorucci, S. Gastroenterology 2007, 132, 261.
(b) Chattopadhyay, M.; Kodela, R.; Nath, N.; Dastagirzada, Y. M.; Velazquez-Martinez, C. A.; Boring, D.; Kashfi, K. Biochem. Pharmacol. 2012, 83, 715.
[11] Lee, Z. W.; Zhou, J.; Chen, C. S.; Zhao, Y.; Tan, C. H.; Li, L.; Moore, P. K.; Deng, L. W. PLoS One 2011, 6, e21077.
[12] Devarie-Baez, N. O.; Bagdon, P. E.; Peng, B.; Zhao, Y.; Park, C.-M.; Xian, M. Org. Lett. 2013, 15, 2786.
[13] Fukushima, N.; Ieda, N.; Sasakura, K.; Nagano, T.; Hanaoka, K.; Suzuki, T.; Miyata, N.; Nakagawa, H. Chem. Commun. (Camb.) 2014, 50, 587.
[14] Fukushima, N.; Ieda, N.; Kawaguchi, M.; Sasakura, K.; Nagano, T.; Hanaoka, K.; Miyata, N.; Nakagawa, H. Bioorg. Med. Chem. Lett. 2015, 25, 175.
[15] Zhou, Z.; von Wantoch Rekowski, M.; Coletta, C.; Szabo, C.; Bucci, M.; Cirino, G.; Topouzis, S.; Papapetropoulos, A.; Giannis, A. Bioorg. Med. Chem. 2012, 20, 2675.
[16] Zheng, Y.; Yu, B.; Ji, K.; Pan, Z.; Chittavong, V.; Wang, B. Angew. Chem., Int. Ed. 2016, 55, 4514.
[17] Steiger, A. K.; Pardue, S.; Kevil, C. G.; Pluth, M. D. J. Am. Chem. Soc. 2016, 138, 7256.
[18] Zheng, H.; Weng, L. L. CN 201710475428, 2017.
[19] Achterhof, M.; Conaway, R. F.; Boord, C. E. J. Am. Chem. Soc. 1931, 53, 2682.
[20] Romero, R.; Erez, O.; Huttemann, M.; Maymon, E.; Panaitescu, B.; Conde-Agudelo, A.; Pacora, P.; Yoon, B. H.; Grossman, L. I. Am. J. Obstet. Gynecol. 2017, 217, 282.
[21] Ye, Y.; Li, X. J.; Zeng, Z. Z. Chin. J. Appl. Chem. 2005, 22, 1060(in Chinese). (叶琰, 李秀娟, 曾正志, 应用化学, 2005, 22, 1060.)
[22] (a) Moghimi, A.; Khavassi, H.; Dashtestani, F.; Kordestani, D.; Jafari, A. E.; Maddah, B.; Moosavi, S. J. Mol. Struct. 2011, 996, 38.
(b) Veisi, H.; Masti, R.; Kordestani, D.; Safaei, M.; Sahin, O. J. Mol. Catal. A:Chem. 2014, 385, 61.
(c) Alizadeh, A.; Khodaei, M. M.; Abdi, G.; Kordestani, D. Bull. Korean Chem. Soc. 2012, 33, 3640.
[23] Zhang, Z. L.; Bai, B.; Song, H. Chem. Eng. 2012, 26, 34(in Chinese). (张子龙, 白冰, 宋华, 化学工程师, 2012, 26, 34.)
[24] Guan, X. C.; Peng, H. Y. J. Anyang Inst. Technol. 2012, 11, 25(in Chinese). (关秀存, 彭红艳, 安阳工学院学报, 2012, 11, 25.)
[25] Koh, M.; Lee, J.-C.; Min, C.; Moon, A. Bioorg. Med. Chem. 2013, 21, 2305.
[26] Zou, J. Y.; Feng, J. T. Sulphuric Acid Ind. 2013, 38(in Chinese). (邹婕妤, 冯俊婷, 硫酸工业, 2013, 38.)

二甲双胍硫化氢盐的合成、结构鉴定和稳定性研究

Synthesis, Structural Characterization and Stability Evaluation of Metformin Hydrosulfide

PDF

补充材料

可视化

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 0

编辑推荐

相关统计

本文评价